Clinical Trials Logo

Clinical Trial Summary

Preventive treatment with azithromycin reduces the prevalence fo Bronchiolitis Obliterans Syndrome after lung transplantation.


Clinical Trial Description

- Prospective, interventional, randomized, double-blind, placebo-controlled trial.

- Clinical setting (tertiary University Hospital).

- Investigator-driven, no pharmaceutical sponsor.

- Lung transplant recipients.

- Add-on of study-drug (placebo or azithromycin) to 'standard of care' (standardized, routine immunosuppressive and infectious prophylactic protocol).

- 1:1 inclusion ratio (placebo:azithromycin).

- Randomisation at discharge after informed consent. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01009619
Study type Interventional
Source Katholieke Universiteit Leuven
Contact
Status Completed
Phase Phase 4
Start date September 2005
Completion date December 2009

See also
  Status Clinical Trial Phase
Completed NCT00771875 - Randomized Trial for Mixed Acute Rejection Phase 2
Completed NCT00369382 - Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients Phase 4
Not yet recruiting NCT05072951 - Urine Biomarker for Kidney Transplant Rejection
Completed NCT01211509 - Montelukast in Bronchiolitis Obliterans Syndrome Phase 4
Recruiting NCT01066689 - Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation Phase 3
Completed NCT00251004 - Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients Phase 3
Completed NCT00254709 - Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients Phase 4
Recruiting NCT04851145 - Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation. N/A
Completed NCT00001984 - Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys Phase 2
Completed NCT04488094 - Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation Phase 2
Not yet recruiting NCT03147157 - The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation N/A
Completed NCT00761787 - Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY N/A
Completed NCT00000137 - Collaborative Corneal Transplantation Studies (CCTS) Phase 3
Completed NCT00266123 - Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients Phase 4
Completed NCT00035555 - Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney Phase 2
Completed NCT00001858 - Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants
Completed NCT00895583 - Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients Phase 4
Completed NCT00089947 - A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection Phase 2
Enrolling by invitation NCT05285878 - Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation Phase 2
Active, not recruiting NCT00619528 - HLA-Identical Sibling Renal Transplant Tolerance N/A